US2007258945A1PendingUtilityA1

G-GSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction

Assignee: UNIV NORTHWESTERNPriority: Oct 27, 2003Filed: Apr 5, 2007Published: Nov 8, 2007
Est. expiryOct 27, 2023(expired)· nominal 20-yr term from priority
A61P 9/10A61K 38/193
47
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to methods of using Granulocyte Colony Stimulating Factor (G-CSF) polypeptide in conjunction with reperfusion therapy in the treatment of acute myocardial infarction or other ischemic events. This treatment can be used alone or in combination with other well-known methods of treatment.

Claims

exact text as granted — not AI-modified
1 - 7 . (canceled)  
   
   
       8 . A kit containing components for treating myocardial infarction or occlusion in an artery comprised of: 
 a) a composition comprising G-CSF polypeptide; and    b) optionally, at least one additional factor selected from the group consisting of: EPO, SCF, M-GDF, GM-CSF, M-CSF, CSF-1, IL-1, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-1, IL-11, IL-12, IGF-1, LIF, interferon, a neurotrophic factor, a fibroblast growth factor, and human growth hormone.    
   
   
       9 - 10 . (canceled)

Join the waitlist — get patent alerts

Track US2007258945A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.